In the two studies showing an advantage of CSII on MDI,10,11 baseline patient characteristics suggested more difficult to treat diabetes with higher insulin requirement, higher HbA1c level and a higher number of insulin injections in comparison with the two studies showing similar efficacy of CSII and MDI.8,9. This evidence concerns the gene INS and diabetes mellitus.